Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia. (Q43046314)
Jump to navigation
Jump to search
scientific article published in May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia. |
scientific article published in May 2010 |
Statements
Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia (English)
S Shah
B Gil-Extremera
J F Paolini
H Giezek
K Vandormael
A Mao
C McCrary Sisk